Key facts
- It has raised $11.0M across 3 recorded rounds; the latest was Seed Round ($250K) in Dec 2025.
- Mel-Mont Medical has filed 3 Form Ds with the SEC since 2020, most recently Dec 2025 ($250K sold to 3 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 3 rounds
- ·Watchlist + deal alerts for Mel-Mont Medical
Funding rounds
3 roundsAbout Mel-Mont Medical
Developer of advanced molecular diagnostics intended for the early detection and prevention of RNA-virus-related pathologies. The company's platform utilizes patented and clinically proven technologies to identify high-risk human papillomavirus and respiratory viruses, enabling healthcare providers to enhance patient outcomes through timely interventions and improved disease management strategies.
- Sector
- Healthcare
- HQ
- Doral, FL, United States
- Founded
- 2014
- Employees
- 4
- Website
- mel-montmedical.com/
- Ownership
- Privately Held (backing)
Mel-Mont Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Mel-Mont Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Mel-Mont Medical in its N-PORT filings yet. We sweep new filings monthly.